TY - JOUR T1 - Oral Drug Delivery Technologies—A Decade of Developments JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 529 LP - 543 DO - 10.1124/jpet.118.255828 VL - 370 IS - 3 AU - G. Kaur AU - M. Arora AU - M.N.V. Ravi Kumar Y1 - 2019/09/01 UR - http://jpet.aspetjournals.org/content/370/3/529.abstract N2 - Advanced drug delivery technologies, in general, enable drug reformulation and administration routes, together contributing to life-cycle management and allowing the innovator to maintain the product monopoly. Over the years, there has been a steady shift from mere life-cycle management to drug repurposing—applying delivery technologies to tackle solubility and permeability issues in early stages or safety and efficacy issues in the late stages of drug discovery processes. While the drug and the disease in question primarily drive the choice of route of administration, the oral route, for its compliance and safety attributes, is the most preferred route, particularly when it comes to chronic conditions, including pain, which is not considered a disease but a symptom of a primary cause. Therefore, the attempt of this review is to take a stock of the advances in oral delivery technologies that are applicable for injectable to oral transformation, improve risk-benefit profiles of existing orals, and apply them in the early discovery program to minimize the drug attrition rates. ER -